Anika Therapeutics Inc.

Anika Therapeutics Inc. Overview

Company Headquarters: Massachusetts, US

Founded: 1992

Workforce: ~133

Company Working: Anika Therapeutics is an orthopedic and regenerative medicines company. Its offers products based on hyaluronic acid, biocompatible polymer, and natural chemical. In the US, the company owns 19 patents and internationally 187 patents. In 2018, the company’s top five customers account 86% of the revenue, e.g., Mitek, a part of Johnson & Johnson medical device company and the global leader in orthopedic sports medicine accounted 73% of the company sales revenue. The company primarily depends on a small number of large customers, particularly Mitek, for the majority of its sales revenues. The company markets and distribute its products in the US, Italy, and European countries, among others.

Strategy

Anika Therapeutics Inc. strongly emphasizes the continuous launch of products and has a wide range of products in its clinical pipeline. For the success of these products, the company invests in sales and marketing. Moreover, it focuses on maximizing the growth of its core product segments. It also aims at optimizing the growth of core product segments.

Company Snapshot

$103.3M

Revenue

133

Employees

1992

Founded

Massachusetts, US

Headquarters

SWOT Analysis

Strengths

Unique and innovative product
Huge customer base
Large distribution channel
Strong marketing strategies
An integrated orthopedic medicines company
Develops proprietary HA technology and regenerative therapies
Wide geographic presence puts company in strong market position
Unique and innovative products

Weaknesses

Increasing cost of operations
Depended on one product for revenue generation
Inability to increase revenues over extended period is a sign of operating weakness
Weak product revenue for businesses other than its orthobiologics franchise would hamper profit

Opportunities

Extended healthcare need
New product development
Acquisitions and in-licensing development opportunities
Strategic collaborations with other pharmaceutical companies to boost R&D
Mergers and acquisitions to brace position in the market
New product launches to gain maximum market share
Product development

Threats

Patent infringements
Stringent regulations policies
Increasing competition
Natural calamities appear to have adverse longer-term consequences for economic growth and development
A weaker domestic currency stimulates exports and makes imports more expensive. Thus, foreign exchange rate risks market growth
Risks related to Intellectual Property Rights which could have a material impact on company’s business
Compliance with stringent regulatory policies is costly and time consuming, failure to which may result in recall of products
Stringent regulations

Product Offering

Anika Therapeutics Inc.
- Orthobiologics
- Dermal
- Hyaluronic Acid

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.